. The Cntd1 GT allele severely reduces or eliminates Cntd1 function. (a) A gene trap embryonic stem cell line obtained from the Knockout Mouse Consortium (Knockout Mouse Project) was used to generate a targeted gene trap mouse line. CRE-mediated excision of the neo cassette was achieved by crossing mice bearing the initial targeted allele (top) to a Spo11-Cre mouse line (Lyndaker et al., 2013) followed by breeding the neo-excised progeny through several generations to achieve a fully neo-excised genetrap allele (bottom) that we have named Cntd1 GT/+ heterozygous, and Cntd1 GT/GT homozygous mutant testes, deduced from RT-PCR analyses (some shown in c), quantitative PCR (not depicted), and expression of LacZ protein (not depicted). WT animals only express the normal transcript, comprising exons 1-7. In Cntd1 GT/+ heterozygotes and Cntd1
GT/GT homozygotes, in addition to producing the expected major transcript encoding exon 1-LacZ, the Cntd1 GT allele also produces a minor transcript in low abundance, in which a cryptic splice donor near the end of exon 1 is spliced to a cryptic exon comprising a portion of the vectorderived splice acceptor cassette (SA), which is in turn spliced to exon 2; this minor transcript encodes a predicted protein with a 37-amino acid sequence inserted into the middle of  helix #1 of the N-terminal cyclin box of CNTD1. Because the N-terminal cyclin box is highly constrained structurally, this insertion is predicted to severely disrupt protein structure, stability, and function. Colored arrows indicate primer pairs used to detect different transcript species in the RT-PCR analysis depicted in c. (c) Example RT-PCR analyses used to deduce the structures of the transcripts produced by the Cntd1 GT allele. For each gel, RT-PCR was performed using RNA extracted from wild-type (WT), Cntd1
GT/+ heterozygote (Het), or Cntd1 GT/GT mutant (Mut) testes. Box 1 shows that no WT transcripts are detected in Cntd1 GT/GT homozygotes; only the insert-containing transcripts are detected using the exon 1-exon 2 primer pair. The arrowhead shows the larger PCR product of the mutant allele. IRES, internal ribosome entry site. GT/GT males (means ± SD). EP, early pachynema; MP, midpachynema; LP, late pachynema; DIP, diplonema. Mann-Whitney U tests were performed to show statistically significant differences between WT and mutant CDK4 counts at midpachynema (P < 0.001) and late pachynema (P < 0.0001). (n-s) Meiotic marker localization during pachynema in oocytes from Cntd1 +/+ (n-p) and Cntd1 GT/GT (q-s) females, stained with antibodies against SYCP3 and either MSH5 (n, o, q, and r) or MLH1 (p and s). Bars, 10 µm (bar in s applies to n-s). Figure S3 . Predicted cyclin-binding motifs and CDK phosphorylation sites in HEI10, RNF212, and MutS. (a-c) Sequences of the indicated proteins, with predicted cyclin-binding RXL motifs highlighted in magenta and potential CDK phosphorylation sites [S/T]P highlighted in green. In a, blue highlighting indicates the amino acid segment (including the RXL motif) that is absent in the mutant HEI10 protein encoded by the Hei10 mei4 allele. Yellow highlighting indicates the portions of the proteins that are conserved among diverse animals and plants (a and c) or among diverse animals (b); gray indicates regions that are poorly conserved or nonconserved. Note that in RNF212, MSH4, and MSH5, the majority of [S/T]P sites are located in nonconserved N-or C-terminal tails. In b, the gray sequence is italicized and underlined to indicate that this region of RNF212 is highly diverged even within mammals.
